Published price vs quote-only
Embody vs Wellorithm: Which One Publishes Its Price? (2026)
Embody or Wellorithm? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.6 and 7.5 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
If Embody and Wellorithm are the two tabs still open, the deciding information is not on either homepage — it is in what happens after the first month.
A discount off an undisclosed number is not a price. Wellorithm quotes after intake, while Embody states Semaglutide $69/mo (was $299), tirzepatide $119/mo on the way in — which makes one of these two comparable in advance and the other not.
Below, the two programs are set against the things that change the bill — the advertised rate, the rate after the promotion expires, the medication class and the inclusions. Where a figure is not published, that is stated rather than estimated.
The short answer
- Easier to price in advance
- Embody — Semaglutide $69/mo (was $299), tirzepatide $119/mo. The other side quotes after intake, so a like-for-like total is not available before you apply.
- Most support for the money
- Wellorithm — Virtual consultations with licensed clinicians.
- Tirzepatide access
- Embody — Tirzepatide at $119/mo; the other side publishes semaglutide only.
- Easiest to pay for
- Embody — Neither publishes financing; both expect the full amount monthly.
Embody vs Wellorithm at a glance
This is the whole comparison in one screen. The sections underneath explain which of these rows should decide it.
| Embody | Wellorithm | |
|---|---|---|
| Advertised price | Semaglutide $69/mo (was $299), tirzepatide $119/mo | Priced after the eligibility quiz |
| Rate after promotions | $69/mo | not published before intake |
| Pricing structure | Published rate per medication | Quoted only after intake |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide and compounded tirzepatide |
| Price transparency | Published upfront | Quote only, after intake |
| Tirzepatide | $119/mo | Not published |
| Support model | No coaching program stated | No coaching program stated |
| Shipping | Free shipping, 1-2 day delivery after approval | Medication shipped to your home |
| Payment options | Card only, no financing published | Card only, no financing published |
| Patient reviews | 11,250 | 3,240 |
| eRxDoctor score | 7.6/10 | 7.5/10 |
The real cost: six months and twelve
The cheapest first month and the cheapest year are frequently different providers. These are the totals — six months and twelve — using each provider's own published rates and best available plan.
| Embody | Wellorithm | |
|---|---|---|
| First month | $69 | Not published |
| Months 2 onward | $69/mo | Not published |
| 6-month total | $414 | Not computable |
| 12-month total | $828 | Not computable |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Wellorithm: pricing is not published; you receive a quote only after completing the intake quiz. Treat any comparison that quotes one as an estimate someone else has made for you.
Pricing you can check, and pricing you cannot
With Embody the arithmetic is available in advance — Semaglutide $69/mo (was $299), tirzepatide $119/mo, on published rate per medication terms — so it can be compared against anything else on the market.
Wellorithm runs the other way around — pricing is not published; you receive a quote only after completing the intake quiz. There are defensible reasons for that; personalized plans genuinely do vary. The practical effect is still that you cannot comparison-shop it, and a completed intake is exactly the moment a quote lands with the most leverage.
If you do go through Wellorithm's intake, ask for the month-two price in writing before you pay for month one. That single question resolves most of the disclosure gap.
How Embody works
Embody positions itself on the lowest published semaglutide price on this list, with no lock-in. Semaglutide $69/mo (was $299), Tirzepatide $119/mo
You start with licensed provider review handled entirely online; medication arrives via free shipping, 1-2 day delivery after approval. The price behaves as published rate per medication.
24/7 support for dosing and side-effect questions. The formulary covers compounded semaglutide and compounded tirzepatide.
Embody pros
- Lowest entry price on this list at $69/month for compounded semaglutide
- Compounded tirzepatide available at $119/month
- Free shipping with fast 1–2 day delivery after approval
- No long-term commitment; cancel without penalty
Embody cons
- Fewer premium features (no integrated coaching or advanced monitoring) than higher-priced platforms
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- $69 semaglutide pricing is a limited-time offer that may increase
Where it gives ground to Wellorithm: a limited-time rate with few of the extras that higher-priced platforms bundle.
Wellorithm in detail
Take the 2-Minute Quiz to Check Your Eligibility Against Embody, that puts it in the position of the harder of the two to price in advance.
The process is 2-minute eligibility quiz, then medication shipped to your home. On money, expect quoted only after intake — quote only, after intake.
What continues after the first shipment: virtual consultations with licensed clinicians. Formulary: compounded semaglutide and compounded tirzepatide.
Wellorithm pros
- Strong fit for patients in states with limited GLP-1 telehealth access
- Both compounded semaglutide and tirzepatide available
- Licensed clinicians in all 50 states, broader coverage than many smaller platforms
- No insurance pre-authorization required
Wellorithm cons
- Pricing is not published, you only get a quote after completing the intake quiz
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Smaller, less-established platform with limited public reviews
Set beside Embody, the thing to weigh: a smaller platform with no published price and limited public review volume.
Picking between them
Choose Embody if:
- you want to start on their timeline: licensed provider review handled entirely online
- delivery works the way you want it to: free shipping, 1-2 day delivery after approval
- you want tirzepatide available without changing provider later
- you want the full price in front of you before completing an intake
Choose Wellorithm if:
- delivery works the way you want it to: medication shipped to your home
- you want to start on their timeline: 2-minute eligibility quiz
- the level of clinical contact suits you: virtual consultations with licensed clinicians
- you would get real value from licensed clinicians in all 50 states, which matters in the states where GLP-1 telehealth coverage is thin
What each one gives up
On price. Only Embody publishes a rate you can plan against (Semaglutide $69/mo (was $299), tirzepatide $119/mo). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On clinical contact. Embody provides 24/7 support for dosing and side-effect questions. Wellorithm provides virtual consultations with licensed clinicians. Both are asynchronous-first services and neither replaces a physician who can examine you.
On medication. Embody covers compounded semaglutide and compounded tirzepatide; Wellorithm covers compounded semaglutide and compounded tirzepatide. Only Embody publishes a tirzepatide route, which matters if semaglutide underdelivers.
On access. Embody advertises licensed provider review handled entirely online and free shipping, 1-2 day delivery after approval; Wellorithm advertises 2-minute eligibility quiz and medication shipped to your home. Coverage differs too — not published against all 50 states — which decides the question before price does if you are in a restricted state.
The medication, not the platform
Before either program's marketing claims, the underlying evidence — which belongs to the medication, not the platform.
The NIH position is that weight-management medication works alongside changes in eating and activity, not instead of them, per NIH, NIDDK.
Cardiovascular benefit has been demonstrated for semaglutide in a specific population: adults with overweight or obesity and existing cardiovascular disease but no diabetes, per NEJM, SELECT.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
Embody vs Wellorithm: common questions
Which is cheaper to start, Embody or Wellorithm?
Only Embody publishes a first-month figure (Semaglutide $69/mo (was $299), tirzepatide $119/mo). The other quotes after intake, so a starting-cost comparison is not available in advance.
How much does Wellorithm cost?
Pricing is not published; you receive a quote only after completing the intake quiz. That is the honest answer, and it is the main practical drawback next to Embody, which publishes Semaglutide $69/mo (was $299), tirzepatide $119/mo upfront. If you go through the intake, ask for the month-two and maintenance-dose prices in writing before paying for the first month.
Can I switch from Embody to Wellorithm later?
You can, and people do — usually when an introductory price expires. Budget for a repeat intake and a short overlap in supply, and confirm what happens to any unused portion of a multi-month plan before you cancel it.
Is Embody or Wellorithm better for a first GLP-1 prescription?
For a first prescription, weight support over price. Embody offers more contact (24/7 support for dosing and side-effect questions), which matters most in the first eight weeks when side effects and titration questions are at their peak. Once you know how you tolerate the medication, the cheaper program becomes the rational choice.
Do Embody and Wellorithm prescribe the same medication?
Both dispense compounded GLP-1 preparations. Embody lists compounded semaglutide and compounded tirzepatide and Wellorithm lists compounded semaglutide and compounded tirzepatide, so the molecules overlap even where the formulary does not match exactly.
Does Embody or Wellorithm offer tirzepatide?
Embody does, at $119/mo. Wellorithm publishes compounded semaglutide and compounded tirzepatide only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
What happens if I stop taking the medication?
Both programs are month to month, which makes stopping easy and makes the consequence of stopping the thing to plan for: published extension data shows most of the lost weight returns within about a year. That is an argument for choosing on annual cost rather than entry price.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. Embody leads on the lowest published semaglutide price on this list, with no lock-in; Wellorithm leads on licensed clinicians in all 50 states, which matters in the states where GLP-1 telehealth coverage is thin.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
Whichever way you go, the medication is the same class of drug and the clinical questions belong to a clinician. What you are choosing here is a billing model and a support structure.
Keep comparing
- Embody vs MaximusBudget vs premium
- Embody vs He & She MDBudget vs premium
- Wellorithm vs Start WillowPublished price vs quote-only
- Wellorithm vs Sprout HealthPublished price vs quote-only
- Shed vs GalaPublished price vs quote-only
- Shed vs MeasuredPublished price vs quote-only
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Embody or Wellorithm, and does not sell treatment. Read our ranking methodology.